This decision is in-line with the FDA’s recommendation not to remove textured implants or other types of breast implants in patients who have no symptoms of Breast Implant Associated Anaplastic Large Cell Lymphoma (“BIA-ALCL”) due to the low risk of developing BIA-ALCL. As part of this program, Allergan will not provide surgical fee assistance to revision patients. The decision to get a breast implant revision is a personal decision between patients and their plastic surgeons, and must be decided based on the appropriate discussion of benefits and risks. If you are a patient with BIOCELL® textured breast implants in Pasadena, San Gabriel Valley, Inland Empire, or Orange County area, and would like to discuss your replacement options, you may request a consultation online or call Wang Plastic Surgery at (888) 360-6688 today to schedule your appointment. The program will run for 24 months, until July 24, 2021, and will apply to revision surgeries on or after the date of the recall announcement, July 24, 2019. who, as a result of the recall announcement on July 24, 2019, choose to replace their BIOCELL® textured devices with smooth devices in consultation with their plastic surgeon, Allergan will provide Allergan smooth device replacements for free.
0 Comments
Leave a Reply. |